[1]
“EVALUATION OF CARDIOVASCULAR DISEASE AND FATTY LIVER DISEASE IN TYPE 2 DIABETES SUBJECTS ON ULTRASONOGRAPHY”, Int. Res. J. Pharm., vol. 15, no. 6, pp. 35–39, Nov. 2024, Accessed: Jun. 01, 2026. [Online]. Available: https://irjponline.org/index.php/irjp/article/view/92